Anbison Lab Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANBISON LAB, and what generic and branded alternatives to ANBISON LAB drugs are available?
ANBISON LAB has four approved drugs.
Drugs and US Patents for Anbison Lab
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anbison Lab | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 212948-002 | Sep 30, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Anbison Lab | MONTELUKAST SODIUM | montelukast sodium | TABLET;ORAL | 205683-001 | Jan 12, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Anbison Lab | MONTELUKAST SODIUM | montelukast sodium | TABLET, CHEWABLE;ORAL | 205695-002 | Nov 5, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Anbison Lab | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 207224-001 | Jun 30, 2017 | AB3 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Anbison Lab | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 207224-002 | Jun 30, 2017 | AB3 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Anbison Lab | MONTELUKAST SODIUM | montelukast sodium | TABLET, CHEWABLE;ORAL | 205695-001 | Nov 5, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Anbison Lab | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 212948-003 | Sep 30, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.